BioShai is developing PDx, a simple blood test for the early diagnosis of Parkinsons disease. PDx is based on the measurement of the level of expression of a set of genes. The test can be combined with other clinical data to provide a more complete diagnosis and help physicians decide on the best course of treatment. BioShai is a portfolio company of Youdim Pharmaceuticals incubator.